Abstract
Drug research and development (R&D) is an essential activity in the (bio)pharmaceutical sector. To meet the constant demands of the sector, high-throughput screening techniques such as RNA sequencing (RNA-Seq) have been widely used to accelerate drug R&D and reduce costs related to this systematic process. This is because RNA-Seq allows you to identify therapeutic targets, predict the mec…